Abstract
Osteogenesis imperfecta (OI) is an inherited connective tissue disorder. Left ventricle dilation and valve insufficiency are complications in patients with OI and such patients are at high risk of mortality and complications related to bleeding and tissue friability during cardiac surgery. Valve dehiscence due to extreme friability of the annulus is a major complication of cardiac valve replacement with OI. We describe OI in a male patient who underwent double valve replacement with mechanical valves using a tissue protective method to prevent valve dehiscence.
Similar content being viewed by others
References
Roubelakis A, Moorjani N, Gallagher P, Ohri SK. Aortic root and hemiarch replacement in osteogenesis imperfecta. Asian Cardiovasc Thorac Ann. 2012;20:68–70.
Stein D, Kloster FE. Valvular heart disease in osteogenesis imperfecta. Am Heart J. 1977;94(5):637–41.
Byers PH, Steiner RD. Osteogenesis Imperfecta. Annu Rev Med. 1992;43:269–82.
Radunovic Z, Wekre LL, Diep LM, Steine K. Cardiovascular abnormalities in adults with osteogenesis imperfecta. Am Heart J. 2011;161(3):523–9.
Bonita RE, Cohen IS, Berko BA. Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography. 2010;27(1):69–73.
Wong RS, Follis FM, Shively BK, Wernly JA. Osteogenesis imperfecta and cardiovascular diseases. Ann Thorac Surg. 1995;60(5):1439–43.
McKay R, Yacoub MH. Clinical and pathological findings in patients with “floppy” valves treated surgically. Circulation. 1973;48(1 Suppl III):63–73.
Azuma T, Yamazaki K, Saito S, Kurosawa H. Aortic valve replacement in Behcet’s disease: surgical modification to prevent valve detachment. Eur J Cardio Thorac Surg. 2009;36:771–2.
Dellgren G, Feindel CM, Bos J, Ivanov J, David TE. Aortic valve replacement with the Toronto SPV: long-term clinical and hemodynamic results. Eur J Cardiothorac Surg. 2002;21(4):698–702.
Jamieson WR, Riess FC, Raudkivi PJ, Metras J, Busse EF, Goldstein J, et al. Medtronic mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg. 2011;142(2):302–7.
McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg. 2010;89(5):1410–6.
Lamanna A, Fayers T, Clarke S, Parsonage W. Valvular and aortic disease in osteogenesis imperfecta. Heart Lung Circ. 2013;20(10):801–10.
Koentges D, van de Werf F, Stalpaert J, Goddeeris P, de Geest H. Aortic and mitral valve replacement in osteogenesis imperfect. Report of a case. Acta Cardiol. 1986;41(2):147–53.
Aoki T, Kuraoka S, Ohtani S, Kuroda Y. Aortic valve replacement in a woman with osteogenesis imperfecta. Ann Thorac Cardiovasc Surg. 2002;8(1):51–3.
Bennett JM, Gourassas J, Stevens S. Double valve replacement in a patient with osteogenesis imperfecta. Eur J Cardiothorac Surg. 1987;1:46–8.
Conflict of interest
None of the authors have any conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sumi, M., Ariyoshi, T., Matsukuma, S. et al. Surgical technique of double valve replacement in a patient with osteogenesis imperfecta. Gen Thorac Cardiovasc Surg 64, 220–223 (2016). https://doi.org/10.1007/s11748-014-0433-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0433-7